{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:50:03Z","timestamp":1790898603005,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T00:00:00Z","timestamp":1399248000000},"content-version":"vor","delay-in-days":1189,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1593\/tlo.10172","type":"journal-article","created":{"date-parts":[[2014,3,25]],"date-time":"2014-03-25T09:54:34Z","timestamp":1395741274000},"page":"9-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Interleukin 22 Signaling Promotes Cell Growth in Mantle Cell Lymphoma"],"prefix":"10.1016","volume":"4","author":[{"given":"Pascal","family":"Gelebart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoulika","family":"Zak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Dien-Bard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1593\/tlo.10172_bib1","first-page":"229","article-title":"Classification of Tumours of Haematopoietic and Lymphoid Tissues","volume":"Volume 2","author":"Swerdlow","year":"2008"},{"key":"10.1593\/tlo.10172_bib2","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1182\/blood-2009-02-179739","article-title":"How I treat mantle cell lymphoma","volume":"114","author":"Ghielmini","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1593\/tlo.10172_bib3","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1080\/10428190701851364","article-title":"Therapeutic options in mantle cell lymphoma","volume":"49","author":"Gill","year":"2008","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1593\/tlo.10172_bib4","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1200\/JCO.2008.16.8435","article-title":"Improvement of overall survival in advanced stage mantle cell lymphoma","volume":"27","author":"Herrmann","year":"2009","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1593\/tlo.10172_bib5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/MOH.0b013e328302c9c5","article-title":"Mantle cell lymphoma: advances in biology and therapy","volume":"15","author":"Smith","year":"2008","journal-title":"Curr Opin Hematol"},{"issue":"5","key":"10.1593\/tlo.10172_bib6","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/jcb.20613","article-title":"Location, location, location: the role of cyclin D1 nuclear localization in cancer","volume":"96","author":"Gladden","year":"2005","journal-title":"J Cell Biochem"},{"issue":"11","key":"10.1593\/tlo.10172_bib7","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1038\/leu.2008.213","article-title":"Specific lentiviral shRNA-mediated knockdown of cyclin D1 in mantle cell lymphoma has minimal effects on cell survival and reveals a regulatory circuit with cyclin D2","volume":"22","author":"Klier","year":"2008","journal-title":"Leukemia"},{"issue":"3","key":"10.1593\/tlo.10172_bib8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2141.2008.07443.x","article-title":"GeneChip analyses point to novel pathogenetic mechanisms in mantle cell lymphoma","volume":"144","author":"Vater","year":"2009","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1593\/tlo.10172_bib9","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.exphem.2009.04.012","article-title":"Identified hidden genomic changes in mantle cell lymphoma using high-resolution single nucleotide polymorphism genomic array","volume":"37","author":"Kawamata","year":"2009","journal-title":"Exp Hematol"},{"issue":"2","key":"10.1593\/tlo.10172_bib10","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2141.2008.07334.x","article-title":"Integrated genomic and expression profiling in mantle cell lymphoma: identification of gene-dosage regulated candidate genes","volume":"143","author":"Schraders","year":"2008","journal-title":"Br J Haematol"},{"issue":"21","key":"10.1593\/tlo.10172_bib11","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1002\/pmic.200800080","article-title":"Signal transduction pathways of mantle cell lymphoma: a phosphoproteome-based study","volume":"8","author":"Cecconi","year":"2008","journal-title":"Proteomics"},{"key":"10.1593\/tlo.10172_bib12","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/978-0-387-39978-2_13","article-title":"Gene expression profiling in malignant lymphomas","volume":"593","author":"Henrickson","year":"2007","journal-title":"Adv Exp Med Biol"},{"issue":"8","key":"10.1593\/tlo.10172_bib13","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.leukres.2005.11.013","article-title":"Genomic imbalances and patterns of karyotypic variability in mantle-cell lymphoma cell lines","volume":"30","author":"Camps","year":"2006","journal-title":"Leuk Res"},{"issue":"4","key":"10.1593\/tlo.10172_bib14","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2141.2005.05630.x","article-title":"Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGFbeta signalling pathways","volume":"130","author":"Rizzatti","year":"2005","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1593\/tlo.10172_bib15","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1182\/blood-2004-10-3999","article-title":"Proteomic analysis of mantle-cell lymphoma by protein microarray","volume":"105","author":"Ghobrial","year":"2005","journal-title":"Blood"},{"issue":"13","key":"10.1593\/tlo.10172_bib16","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1182\/blood-2008-02-139212","article-title":"Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma","volume":"112","author":"Gelebart","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1593\/tlo.10172_bib17","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/path.1253","article-title":"Expression of STAT3 and its phosphorylated forms in mantle cell lymphoma cell lines and tumours","volume":"199","author":"Lai","year":"2003","journal-title":"J Pathol"},{"issue":"4","key":"10.1593\/tlo.10172_bib18","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.4049\/jimmunol.164.4.1814","article-title":"Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9","volume":"164","author":"Dumoutier","year":"2000","journal-title":"J Immunol"},{"issue":"8","key":"10.1593\/tlo.10172_bib19","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/sj.gene.6363716","article-title":"IL-TIF\/IL-22: genomic organization and mapping of the human and mouse genes","volume":"1","author":"Dumoutier","year":"2000","journal-title":"Genes Immun"},{"issue":"5","key":"10.1593\/tlo.10172_bib20","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.jaci.2008.02.026","article-title":"The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29","volume":"121","author":"Commins","year":"2008","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"10.1593\/tlo.10172_bib21","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/sj.cr.7310106","article-title":"Expression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes","volume":"16","author":"Chung","year":"2006","journal-title":"Cell Res"},{"issue":"10","key":"10.1593\/tlo.10172_bib22","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1084\/jem.20061308","article-title":"Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides","volume":"203","author":"Liang","year":"2006","journal-title":"J Exp Med"},{"issue":"7230","key":"10.1593\/tlo.10172_bib23","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nature07537","article-title":"A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity","volume":"457","author":"Cella","year":"2009","journal-title":"Nature"},{"issue":"6","key":"10.1593\/tlo.10172_bib24","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.jaci.2009.03.041","article-title":"IL-22-producing \u201cT22\u201d T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells","volume":"123","author":"Nograles","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1593\/tlo.10172_bib25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1600-0536.2008.01454.x","article-title":"Increased serum levels of IL-22 in patients with nickel contact dermatitis","volume":"60","author":"Ricciardi","year":"2009","journal-title":"Contact Dermatitis"},{"issue":"4","key":"10.1593\/tlo.10172_bib26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nri2522","article-title":"Interleukin-22-producing innate immune cells: new players in mucosal immunity and tissue repair?","volume":"9","author":"Vivier","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"10.1593\/tlo.10172_bib27","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/ni.1770","article-title":"Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells","volume":"10","author":"Trifari","year":"2009","journal-title":"Nat Immunol"},{"issue":"40","key":"10.1593\/tlo.10172_bib28","doi-asserted-by":"crossref","first-page":"31335","DOI":"10.1074\/jbc.M005304200","article-title":"Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R","volume":"275","author":"Xie","year":"2000","journal-title":"J Biol Chem"},{"issue":"20","key":"10.1593\/tlo.10172_bib29","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1016\/j.febslet.2008.07.046","article-title":"Crystal structure of the IL-22\/IL-22R1 complex and its implications for the IL-22 signaling mechanism","volume":"582","author":"Bleicher","year":"2008","journal-title":"FEBS Lett"},{"issue":"5","key":"10.1593\/tlo.10172_bib30","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1529\/biophysj.107.112664","article-title":"Interleukin-22 forms dimers that are recognized by two interleukin-22R1 receptor chains","volume":"94","author":"de Oliveira Neto","year":"2008","journal-title":"Biophys J"},{"issue":"9","key":"10.1593\/tlo.10172_bib31","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.str.2008.06.005","article-title":"Structure of IL-22 bound to its high-affinity IL-22R1 chain","volume":"16","author":"Jones","year":"2008","journal-title":"Structure"},{"issue":"2","key":"10.1593\/tlo.10172_bib32","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/MPA.0b013e3181594258","article-title":"Interleukin 22 receptor 1 expression in pancreas islets","volume":"36","author":"Shioya","year":"2008","journal-title":"Pancreas"},{"issue":"10","key":"10.1593\/tlo.10172_bib33","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1097\/MLG.0b013e31811edd4f","article-title":"Chronic rhinosinusitis with nasal polyps is associated with decreased expression of mucosal interleukin 22 receptor","volume":"117","author":"Ramanathan","year":"2007","journal-title":"Laryngoscope"},{"issue":"4","key":"10.1593\/tlo.10172_bib34","doi-asserted-by":"crossref","first-page":"G1019","DOI":"10.1152\/ajpgi.00239.2006","article-title":"IL-22-mediated liver cell regeneration is abrogated by SOCS-1\/3 overexpression in vitro","volume":"292","author":"Brand","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"5","key":"10.1593\/tlo.10172_bib35","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.intimp.2004.01.008","article-title":"Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells","volume":"4","author":"Nagalakshmi","year":"2004","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"10.1593\/tlo.10172_bib36","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/intimm\/dxf096","article-title":"IL-22, in contrast to IL-10, does not induce Ig production, due to absence of a functional IL-22 receptor on activated human B cells","volume":"14","author":"Lecart","year":"2002","journal-title":"Int Immunol"},{"issue":"6","key":"10.1593\/tlo.10172_bib37","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1365-2133.2008.08785.x","article-title":"Gene expression study of IL10 family genes in vitiligo skin biopsies, peripheral blood mononuclear cells and sera","volume":"159","author":"Ratsep","year":"2008","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1593\/tlo.10172_bib38","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1084\/jem.20082683","article-title":"STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing","volume":"206","author":"Pickert","year":"2009","journal-title":"J Exp Med"},{"issue":"20","key":"10.1593\/tlo.10172_bib39","doi-asserted-by":"crossref","first-page":"6432","DOI":"10.1158\/1078-0432.CCR-07-4401","article-title":"Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts","volume":"14","author":"Zhang","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"22","key":"10.1593\/tlo.10172_bib40","doi-asserted-by":"crossref","first-page":"16006","DOI":"10.1074\/jbc.M611040200","article-title":"The interleukin-22\/STAT3 pathway potentiates expression of inducible nitric-oxide synthase in human colon carcinoma cells","volume":"282","author":"Ziesche","year":"2007","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1593\/tlo.10172_bib41","doi-asserted-by":"crossref","first-page":"8266","DOI":"10.4049\/jimmunol.177.11.8266","article-title":"IL-22-mediated tumor growth reduction correlates with inhibition of ERK1\/2 and AKT phosphorylation and induction of cell cycle arrest in the G2-M phase","volume":"177","author":"Weber","year":"2006","journal-title":"J Immunol"},{"key":"10.1593\/tlo.10172_bib42","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1038\/leu.2008.129","article-title":"Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenecity in ALK+ anaplastic large cell lymphoma","volume":"22","author":"Bard","year":"2008","journal-title":"Leukemia"},{"issue":"4","key":"10.1593\/tlo.10172_bib43","doi-asserted-by":"crossref","first-page":"424","DOI":"10.5858\/2003-127-0424-COMCLC","article-title":"Characterization of 4 mantle cell lymphoma cell lines","volume":"127","author":"Amin","year":"2003","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1593\/tlo.10172_bib44","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1074\/jbc.M007837200","article-title":"Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes","volume":"276","author":"Kotenko","year":"2001","journal-title":"J Biol Chem"},{"issue":"37","key":"10.1593\/tlo.10172_bib45","doi-asserted-by":"crossref","first-page":"33676","DOI":"10.1074\/jbc.M204204200","article-title":"Interleukin-22 (IL-22) activates the JAK\/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10","volume":"277","author":"Lejeune","year":"2002","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1593\/tlo.10172_bib46","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.bcp.2005.04.043","article-title":"Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1\/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma","volume":"70","author":"Shishodia","year":"2005","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10.1593\/tlo.10172_bib47","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.4049\/jimmunol.178.3.1923","article-title":"Selective inhibition of IkappaB kinase sensitizes mantle cell lymphoma B cells to TRAIL by decreasing cellular FLIP level","volume":"178","author":"Roue","year":"2007","journal-title":"J Immunol"},{"issue":"18","key":"10.1593\/tlo.10172_bib48","doi-asserted-by":"crossref","first-page":"12722","DOI":"10.1074\/jbc.M601018200","article-title":"Nuclear factor-kappaB activated by capacitative Ca2+ entry enhances muscarinic receptor-mediated soluble amyloid precursor protein (sAPPalpha) release in SH-SY5Y cells","volume":"281","author":"Choi","year":"2006","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1593\/tlo.10172_bib49","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1158\/1535-7163.MCT-07-0093","article-title":"Notch inhibition in Kaposi's sarcoma tumor cells leads to mitotic catastrophe through nuclear factor-kappaB signaling","volume":"6","author":"Curry","year":"2007","journal-title":"Mol Cancer Ther"},{"issue":"18","key":"10.1593\/tlo.10172_bib50","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1016\/S0968-0896(03)00438-3","article-title":"A novel structural class of potent inhibitors of NF-kappa B activation: structure-activity relationships and biological effects of 6-aminoquinazoline derivatives","volume":"11","author":"Tobe","year":"2003","journal-title":"Bioorg Med Chem"},{"issue":"26","key":"10.1593\/tlo.10172_bib51","article-title":"NF-kappaB mediated enhancement of potassium currents by the chemokine CXCL1\/growth related oncogene in small diameter rat sensory neurons","volume":"5","author":"Yang","year":"2009","journal-title":"Mol Pain"},{"issue":"1","key":"10.1593\/tlo.10172_bib52","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neulet.2008.04.091","article-title":"Laminin activates NF-kappaB in Schwann cells to enhance neurite outgrowth","volume":"439","author":"Armstrong","year":"2008","journal-title":"Neurosci Lett"},{"issue":"24","key":"10.1593\/tlo.10172_bib53","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1021\/jm060630x","article-title":"Substituted trans-stilbenes, including analogues of the natural product resveratrol, inhibit the human tumor necrosis factor alpha-induced activation of transcription factor nuclear factor kappaB","volume":"49","author":"Heynekamp","year":"2006","journal-title":"J Med Chem"},{"issue":"4","key":"10.1593\/tlo.10172_bib54","doi-asserted-by":"crossref","first-page":"G827","DOI":"10.1152\/ajpgi.00513.2005","article-title":"IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration","volume":"290","author":"Brand","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1\u20132","key":"10.1593\/tlo.10172_bib55","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cca.2008.11.009","article-title":"Decreased serum IL-22 levels in patients with systemic lupus erythematosus","volume":"401","author":"Pan","year":"2009","journal-title":"Clin Chim Acta"},{"issue":"4","key":"10.1593\/tlo.10172_bib56","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/ard.2008.097089","article-title":"Decreased plasma IL22 levels, but not increased IL17 and IL23 levels, correlate with disease activity in patients with systemic lupus erythematosus","volume":"68","author":"Cheng","year":"2009","journal-title":"Ann Rheum Dis"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523311800082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523311800082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T14:26:39Z","timestamp":1761834399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523311800082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S1936523311800082"],"URL":"https:\/\/doi.org\/10.1593\/tlo.10172","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin 22 Signaling Promotes Cell Growth in Mantle Cell Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1593\/tlo.10172","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Neoplasia Press Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}